Glenmark Pharma

Glenmark Pharma shares hit record high after US Eye Allergy Drug launch

Glenmark Pharmaceuticals shares soared to a record high on Monday, following the launch of a new eye allergy drug in the US market by its subsidiary, Glenmark Therapeutics Inc.